Akari Therapeutics plc ADS (NASDAQ: AKTX) Stock Information | RedChip

Akari Therapeutics plc ADS (NASDAQ: AKTX)


$1.2500
+0.1000 ( +8.70% ) 12.4K

Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).

Market Data


Open


$1.2500

Previous close


$1.1500

Volume


12.4K

Market cap


$33.09M

Day range


$1.1300 - $1.2600

52 week range


$0.9000 - $4.4000

SEC Filings


Form Type Description Pages Date
8-k 8K-related 20 Sep 18, 2024
4 Insider transactions 2 Sep 18, 2024
3 Insider transactions 2 Sep 18, 2024
424b5 Other 1 Sep 16, 2024
effect Other 1 Sep 13, 2024
s-4 Registration statements 107 Sep 13, 2024
upload Comment letters 2 Sep 11, 2024
corresp Comment letters 1 Sep 11, 2024
8-k 8K-related 92 Sep 06, 2024
s-3 Registration statements 8 Sep 06, 2024

Latest News